Dr. Glenn Weston is a counsel in Dechert’s global finance team in London. Dr. Weston's main area of practice is within the field of securitization, with a particular focus on CLOs.
Dr. Weston has worked on both the buy- and sell-side of transactions, acting for numerous CLO managers, bank arrangers, and third-party equity financial providers in connection with a variety of European CLO transactions (including resets, refinancings and reissuances) and associated loan warehouse facilities.
Dr. Weston regularly advises on structuring US and European CLOs to comply with various European regulatory requirements, including those imposed by the EU and UK securitization regulations.
Before joining Dechert, Dr. Weston trained and worked at two leading U.S. law firms and was seconded for nine months to a leading European investment bank where he acted as the sole in-house counsel for their European CLO trading desk.
Dr. Weston is recommended by The Legal 500 UK 2024 for securitization.
- BAML, as arranger and initial purchaser of the €361.6 million OZLME III DAC European CLO.
- BNP Paribas, as arranger and initial purchaser of the €451.825 million RRE 1 Loan Management DAC European CLO, including assistance with the establishment of the RRE European CLO platform.
- Barclays Bank, as arranger and initial purchaser of the €409.45 million Harvest CLO XXI DAC European CLO.
- Credit Suisse, as arranger and initial purchaser of the €406.75 million Sound Point Euro CLO II Funding DAC European CLO.
- CVC Credit Partners European CLO Management, as manager of the €373.6 million CVC Cordatus Loan Fund XII Designated Activity Company European CLO.
- Deutsche Bank, as arranger and initial purchaser of the €409.8 million Dryden 69 Euro CLO 2018 B.V. European CLO.
- Hayfin Capital Management, as manager in its redemption and winding up of the €400 million Hayfin Ruby II Luxembourg S.C.A. European CLO.
- Natixis, as arranger and placement agent of the €409.3 million Purple Finance CLO 2 Designated Activity Company European CLO.
- Palmer Square Europe Capital Management LLC, on the establishment of a warehouse financing facility and the issuance of €389.6M of CLO notes backed by a portfolio of primarily senior obligations, mezzanine obligations and high yield bonds. This transaction included an ‘uptier priming’ concept that is relatively new to the CLO market.
- Palmer Square Europe Capital Management LLC, as servicer and subordinated noteholder, in connection with the redemption of various notes valued at €389.5 million, originally issued by Palmer Square European Loan Funding 2022-3 DAC.
- Five Arrows Managers LLP and Five Arrows Global Loan Investments PLC, on the establishment of a warehouse financing facility and issuance of €305.8M of CLO notes backed by a portfolio of primarily secured senior loans, secured senior bonds, unsecured senior obligations, mezzanine obligations, second lien loans, corporate rescue loans and high yield bonds. The transaction included a ‘delayed draw’ class of notes, which is relatively novel to the CLO market.
- Anchorage CLO ECM, L.L.C., as collateral manager, in connection with the refinancing of a series of notes totaling US$405 million.
- Churchill Asset Management LLC, as collateral manager, in connection with a US$447 million middle market CLO transaction with Natixis, as lead arranger, and KeyBanc, as the co-structuring agent.
- Redding Ridge Asset Management (UK) LLP, as collateral manager in connection with the issue by RRE 10 Loan Management Designated Activity Company of various notes totaling €356.6 million.
- MidOcean Capital Partners, as collateral manager, in connection with a US$402 million CLO. Notably, this is MidOcean’s first CLO structured to prohibit investments in obligors whose principal business is directly de-rived from pornography, the production of tobacco or the production or marketing of controversial/nuclear weapons.
Includes matters handled at Dechert or prior to joining the firm.
-
- Durham University, B.Sc., Cellular Biology, 2002, First Class (Hons), Cellular Biology Prize (awarded for coming first in the year in the field of Cellular Biology), John Norton Prize (award for coming first in the year in the field of Biological Sciences)
- University of Cambridge, Ph.D., Immunology, 2007, Received BBSRC CASE scholarship (with industry placement)
- BPP University, GDL, 2009, Commendation
- BPP University, LPC, 2010, Distinction
-
- England and Wales